DTC Corrective Advertising Study From FDA To Examine Similarity Of Message
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s proposed study will assess how exposure to a corrective television ad affects consumer misperceptions about the product.
You may also be interested in...
Labeling Regs Feel Ripple Effects From FDA’s Capsized Cigarette Warnings
A judge’s opinion that requiring graphic images on cigarette packages unconstitutionally compels speech could apply to FDA off-label rules and disclosure requirements.
DTC Decennial Survey: FDA Adds Nurses, Physician Assistants To Queries On Ads
The survey will update findings from a 2002 assessment by physicians on the impact of DTC marketing on their interactions with patients.
Two Companies, Two BARDA Contracts, Two Approaches To Coronavirus
Sanofi follows Janssen in teaming up with HHS' BARDA to develop a COVID-19 vaccine; using technology platform of its Flublok vaccine, Sanofi expects to enter clinical trials in 1 to 1 ½ years.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: